Vyvanse Capsule (2019-08-08)
- Starting date:
- August 8, 2019
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type III
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-70695
Last updated: 2019-08-13
Summary
-
Product:
Vyvanse 20 mg Capsule
Reason
The dissolution in the affected lot is out of specification.
Depth of distribution
Wholesalers
Affected products
Vyvanse 20 mg Capsule
DIN, NPN, DIN-HIM
DIN 02347156
Dosage form
Capsule
Strength
Lisdexamfetamine dimesylate 20 mg
Lot or serial number
AG4982B
Companies
- Recalling Firm
-
Shire Pharma Canada ULC
22 Adelaide St West, Suite 3800
Toronto
M5H 4E3
Ontario
CANADA
- Marketing Authorization Holder
-
Shire Pharma Canada ULC
22 Adelaide St West, Suite 3800
Toronto
M5H 4E3
Ontario
CANADA